Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.96 +0.31 (+0.43%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Gross Profit (2012 - 2026)

Updated

Ani Pharmaceuticals' Gross Profit was $165.89 million in Q2 2026, up 21.3% from $136.76 million a year earlier and up 15.3% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Gross Profit (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ani Pharmaceuticals' Gross Profit was $590.98 million through Jun 30, 2026, up 29.5% year-over-year; for FY2025, it came in at $542.06 million, up 48.8% from FY2024.

  • Gross Profit has now increased for four consecutive years, with a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $364.17 million in FY2024 (+19.3%), $305.3 million in FY2023 (+71.9%), $177.6 million in FY2022 (+53.7%) and $115.53 million in FY2021 (-4.8%).
  • The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q2 2012.
  • Compared with a year earlier, Gross Profit has increased for 17 straight quarters, with growth averaging 35.2% over the last eight quarters.
  • The best year-over-year quarter for Gross Profit over five years was Q1 2023 (growth of 128.7%); the worst was Q4 2021 (a decline of 17.4%).
  • Per Business Quant data, ANIP's Gross Profit in the three quarters before Q2 2026 was $143.88 million (Q1 2026), $146.79 million (Q4 2025) and $134.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ani Pharmaceuticals 1.73 Bn 513.34 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.89 Mn
Mar 31, 2026 143.88 Mn
Dec 31, 2025 146.79 Mn
Sep 30, 2025 134.42 Mn
Jun 30, 2025 136.76 Mn
Mar 31, 2025 124.09 Mn
Dec 31, 2024 110.29 Mn
Sep 30, 2024 85.26 Mn
Jun 30, 2024 80.34 Mn
Mar 31, 2024 88.27 Mn
Dec 31, 2023 78.23 Mn
Sep 30, 2023 83.73 Mn
Jun 30, 2023 74.26 Mn
Mar 31, 2023 69.08 Mn
Dec 31, 2022 57.91 Mn
Sep 30, 2022 50.93 Mn
Jun 30, 2022 38.56 Mn
Mar 31, 2022 30.21 Mn
Dec 31, 2021 27.03 Mn
Sep 30, 2021 27.65 Mn
API Access

Ani Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ANIP&period=max&api_key=YOUR_API_KEY